SPLINT PHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at SPLINT PHARMA is $83,221, based on 119 certified filings from FY 2021 to FY 2026. This is 31% lower than the national H-1B median salary of $120,000. Compensation at SPLINT PHARMA reflects their market positioning, with entry-level roles starting around $75,858 and senior positions reaching $102,107 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at SPLINT PHARMA range from $65,416 at the 10th percentile to $102,107 at the 90th percentile, showing a $36,691 spread across experience levels and roles. The 25th percentile is $75,858 and the 75th percentile is $90,002.

Yes, SPLINT PHARMA actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), SPLINT PHARMA filed 32 H-1B labor condition applications with 29 certified and 0 denied, at a median salary of $80,974. Across FY 2021–2026, they have filed 143 total H-1B applications with 119 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. SPLINT PHARMA sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), SPLINT PHARMA filed 32 H-1B applications, with 29 certified and 0 denied. Over 6 years of data, SPLINT PHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

SPLINT PHARMA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 143 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating SPLINT PHARMA as a potential H-1B sponsor.

This is an excellent approval rate, indicating SPLINT PHARMA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

SPLINT PHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 119 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles SPLINT PHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at SPLINT PHARMA:

The most frequently sponsored role is Manufacturing Engineer with 8 filings at a median salary of $83,221. This is followed by Research Scientist (6 filings) and Qc Associate.

SPLINT PHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where SPLINT PHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top SPLINT PHARMA H-1B locations:

The largest H-1B hub for SPLINT PHARMA is New York, NY with 21 filings at a median salary of $86,050. The highest-paying location is Malvern, PA at $97,261 median. Salaries range from $62,150 to $97,261 across office locations.

SPLINT PHARMA's median H-1B salary has changed by -4% from FY 2021 ($84,614) to FY 2026 ($80,974). Tracking salary trends over time reveals how SPLINT PHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at SPLINT PHARMA.

Year-by-year breakdown:

• FY 2022: $81,931 (31 certified)
• FY 2023: $88,109 (14 certified)
• FY 2024: $78,374 (5 certified)
• FY 2025: $93,392 (9 certified)
• FY 2026: $80,974 (29 certified)

Salary levels have remained relatively stable at SPLINT PHARMA.

SPLINT PHARMA primarily files H-1B applications at Wage Level II, accounting for 90% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making SPLINT PHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 100% of positions at Level II or higher, SPLINT PHARMA typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

SPLINT PHARMA's median H-1B salary of $83,221 is 31% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating SPLINT PHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare SPLINT PHARMA's offerings with similar companies in your field for a more accurate assessment.

SPLINT PHARMA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. SPLINT PHARMA files 0% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 119 certified filings, SPLINT PHARMA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.